A detailed history of Axa S.A. transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Axa S.A. holds 372,355 shares of SRRK stock, worth $16.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
372,355
Previous 372,250 0.03%
Holding current value
$16.3 Million
Previous $3.1 Million 3.81%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.63 - $9.71 $801 - $1,019
105 Added 0.03%
372,355 $2.98 Million
Q2 2024

Aug 14, 2024

BUY
$7.84 - $16.79 $1,622 - $3,475
207 Added 0.06%
372,250 $3.1 Million
Q1 2024

May 15, 2024

SELL
$13.2 - $17.76 $2.05 Million - $2.75 Million
-154,965 Reduced 29.4%
372,043 $6.61 Million
Q4 2023

Jul 16, 2024

BUY
$6.52 - $20.32 $1.01 Million - $3.15 Million
154,965 Added 41.65%
527,008 $9.91 Million
Q4 2023

Feb 14, 2024

SELL
$6.52 - $20.32 $83,156 - $259,161
-12,754 Reduced 2.36%
527,008 $9.91 Million
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $288,984 - $372,511
48,004 Added 9.76%
539,762 $3.83 Million
Q2 2023

Aug 14, 2023

BUY
$5.79 - $9.11 $2.85 Million - $4.48 Million
491,758 New
491,758 $3.71 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.25B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.